Palitzsch K D, Morales R E, Kronauge J F, Bynum T E, Szabo S
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Eur J Gastroenterol Hepatol. 1995 May;7(5):447-53.
To test the hypothesis that an early increase in vascular permeability is correlated with later gastric mucosal protection in the rat.
Histamine, its agonists (H1, H2, H3) and bradykinin, were either given subcutaneously or intragastrically before the intragastric administration of ethanol. The extravasation of intravenously injected 99mTc-glucoheptonate into the gastric wall and into the gastric contents was used as an indicator of increased permeability. Gastric haemorrhagic lesions where measured by computerized planimetry and ethanol absorption was determined by an ACA Clinical Analyzer.
Histamine and bradykinin increased vascular permeability in the glandular stomach and provided significant gastroprotection, similar to H1-, H2- and H3-agonists, against ethanol-induced gastric haemorrhagic lesions. This gastroprotection was accompanied by low blood levels of ethanol, probably indicating decreased ethanol absorption and the creation of a histodilutional barrier in the stomach by histamine.
These data indicate that an increase in vascular permeability dissipates the concentration, and may delay the absorption, of ethanol in gastric mucosa by creating a perivascular histodilutional barrier. Vascular injury, which is an early pathogenetic factor in the development of ethanol-induced gastric haemorrhagic erosions, may thus be prevented.
验证大鼠早期血管通透性增加与后期胃黏膜保护相关这一假说。
在胃内给予乙醇之前,皮下或胃内给予组胺、其激动剂(H1、H2、H3)和缓激肽。静脉注射的99mTc - 葡庚糖酸盐向胃壁和胃内容物的外渗用作通透性增加的指标。通过计算机辅助平面测量法测量胃出血性病变,并使用ACA临床分析仪测定乙醇吸收情况。
组胺和缓激肽增加腺胃血管通透性,并提供显著的胃保护作用,类似于H1、H2和H3激动剂,可对抗乙醇诱导的胃出血性病变。这种胃保护作用伴随着血液中乙醇水平降低,可能表明乙醇吸收减少以及组胺在胃中形成了组织稀释屏障。
这些数据表明,血管通透性增加通过形成血管周围组织稀释屏障,消散乙醇在胃黏膜中的浓度,并可能延迟其吸收。血管损伤是乙醇诱导的胃出血性糜烂发生发展的早期致病因素,因此可能得以预防。